Replimune (REPL) Exchange Rate Effect (2017 - 2025)
Replimune's (REPL) quarterly Exchange Rate Effect came in at $1.0 million in Q4 2025, up 786.09% year-on-year from $116917.8 in Q4 2024, and down 36.91% quarter-over-quarter from $1.6 million in Q3 2025.
Replimune (REPL) Exchange Rate Effect (2017 - 2025) Analysis & Trends
Replimune has disclosed Exchange Rate Effect across 9 years of filings, most recently posting $1.0 million for Q4 2025.
- Exchange Rate Effect for Q4 2025 came in at $1.0 million, up 786.09% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.5 million (up 929.83% YoY), and the FY2025 annual result was $315000.0, up 466.28% from the prior year.
- Exchange Rate Effect came in at $1.0 million for Q4 2025 at Replimune, down from $1.6 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $2.4 million in Q3 2022 to a low of -$4.5 million in Q1 2023.
- The 5-year median for Exchange Rate Effect is $37000.0 (2023), against an average of $82950.0.
- Across the five-year window, Exchange Rate Effect jumped 21300.0% in 2021 and plunged 4517.14% in 2025, its largest moves.
- Replimune's Exchange Rate Effect stood at $105000.0 in 2021, then tumbled by 107.62% to -$8000.0 in 2022, then plunged by 237.5% to -$27000.0 in 2023, then sank by 459.26% to -$151000.0 in 2024, then surged by 786.09% to $1.0 million in 2025.
- The last three Exchange Rate Effect figures came in at $1.0 million (Q4 2025), $1.6 million (Q3 2025), and -$1.6 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 8.68 Mn |
| 10 | Replimune | 848.00 Mn | 578.86 Mn | - | 1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.04 Mn |
| Dec 31, 2025 | 1.04 Mn |
| Sep 30, 2025 | 1.64 Mn |
| Sep 30, 2025 | 1.64 Mn |
| Jun 30, 2025 | -1.62 Mn |
| Jun 30, 2025 | -1.62 Mn |
| Mar 31, 2025 | 440,000.00 |
| Mar 31, 2025 | 440,000.00 |
| Dec 31, 2024 | -151,000.00 |
| Dec 31, 2024 | -151,000.00 |
| Sep 30, 2024 | 61,000.00 |
| Sep 30, 2024 | 61,000.00 |
| Jun 30, 2024 | -35,000.00 |
| Jun 30, 2024 | -35,000.00 |
| Mar 31, 2024 | -56,000.00 |
| Mar 31, 2024 | -56,000.00 |
| Dec 31, 2023 | -27,000.00 |
| Dec 31, 2023 | -27,000.00 |
| Sep 30, 2023 | -16,000.00 |
| Sep 30, 2023 | -16,000.00 |